Skip to main content
Forschungsinstitut fuer Augenheilkunde
INSTITUTE FOR OPHTHALMIC RESEARCH
FORSCHUNGSINSTITUT FÜR AUGENHEILKUNDE

TÜKliF 1535: Translational strategies for the development of innovative molecular treatment approaches in medicine

Please note, this seminar series will start again in the winter semester 26/27 and take place every Monday at the Institute for Ophthalmic Research (IOR) in Room 2.313 from 4.15 p.m.. How to get there? Please visit the following link.
 

 SPEAKERTITLE
12.10.2026Marius Ueffing/Martin ElmlingerIntroduction: Challenges of translation in medicinal product development. Scope, format and topics, questions from students
19.10.2026Francois Paquet-DurandQualifying a drug target (PKG)
26.10.2026Martin ElmlingerValue chain from development to approved new medications
02.11.2026Marius UeffingRD-Treat: Development program from basic research to translation 
09.11.2026Tobias PetersProof of concept to clinical trials: Regulatory aspects
16.11.2026Marius Ueffing/Martin ElmlingerPresentation and choice of essay topics, questions by students
23.11.2026Tobias PetersClinical trial operations: Tasks & challenges (ICH-GCP)
30.11.2026G. Hanauer (Gast) Safety pharmacology and toxicology of candidate drugs
07.12.2026Marius Ueffing/Martin ElmlingerDiagnostics and translational biomarkers for clinical research
14.12.2026Sven SchnichelsModels for preclinical proof of concept
21.12.2026Mathias SeeligerFunctional biomarkers in ophthalmic preclinical research
11.01.2027Martin ElmlingerClinical evidence of medical devices and in-vitro diagnostics
18.01.2027Hubert LöwenheimFrom translation to business: Do's and Don'ts For Startups
25.01.2027Students, allEssays: Short presentations and discussion
01.02.2027M. Ueffing, M. Elmlinger, N.N.Wrap-up of lecture program, reflections